The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
| Saunders and Walker

In today’s St. Petersburg Times, there is a front page story about Eli Lilly’s apparently successful efforts at marketing the drug Zyprexa to children. The FDA is about to approve the drug’s use for children in spite of the dangerous side effects which include diabetes. Children are even more susceptible to these side effects. In the article, I am quoted as saying that Eli LIlly isn’t fazed by the lawsuits since it sees them as a cost of doing a billion dollar business. Zyprexa, in spite of the dangers, has been a boon for the pharmaceutical company.

For more information on this subject, please refer to the section on Drugs, Medical Devices and Implants.

Comments are closed.